The global disposable insulin-delivery device market size was valued at US$ 14,585.6 million in 2022. In the current year, 2023, the overall market value is estimated to be around US$ 15,780.6 million. The worldwide sales of disposable insulin-delivery devices are forecast to record a CAGR of 7.6% over the next ten years. By the conclusion of this forecast period, the overall market is predicted to be valued at US$ 32,814 million. Growth is attributed to the surge in diabetes-related health expenditures in emerging economies.
Diabetes is one of the most chronic and life-threatening diseases affecting a large world population. Diabetes, also known as diabetes mellitus, is a metabolic disorder wherein the pancreas cannot produce insulin or the body cannot utilize insulin to metabolize glucose.
There are mainly three distinct types of diabetes: Type I Diabetes, Type II Diabetes, and gestational diabetes. The growing prevalence of diabetes is the key factor promoting market growth. The increased prevalence of diabetes has also contributed to the surging mortality rate, which is expected to fuel the growth of the disposable insulin delivery device market.
On the contrary, stringent government rules and regulations governing the product approval process and the high cost of insulin analogs in diabetes care management are expected to hamper the growth of the disposable insulin-delivery device market over the analysis period.
| Report Attributes or Data Points | Details |
|---|---|
| Global Disposable Insulin-delivery Device Market Valuation in 2022 | US$ 14,585.6 million |
| Estimated Global Market Share in 2023 | US$ 15,780.6 million |
| Forecasted Global Market Size by 2033 | US$ 32,814 million |
| Projected Global Market Growth Rate from 2023 to 2033 | 7.6% CAGR |
| Historical Market Growth Rate from 2018 to 2022 | 7.4% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Technological Advancement in Healthcare to Propel the Growth of the Market
Factors such as favorable reimbursement scenarios and strong government support in selected countries, technological advancements in insulin-delivery devices, a growing diabetic population, and rising awareness about insulin-delivery devices are expected to propel the growth of the disposable insulin-delivery market over the analysis period.
Moreover, other factors that are anticipated to augment the market growth include a surge in diabetes-related health expenditure in emerging economies and an increase in the conferences, meetings, and congresses for raising awareness about insulin delivery devices, which in turn mayl assist in the expansion of the market.
Additionally, a rise in research and development activities extends profitable opportunities to the market players during the forecast period. Also, technological advancements in insulin delivery devices mayl assist in expanding the market. Risk factors, such as obesity and being overweight, are highly linked to the incidence of diabetes, which is rising by epidemic proportions, thus rendering a high prevalence of diabetes, which is expected to boost market growth.
Latest trends in the market, such as the launch of high-end insulin pumps, syringes, and pens, are driving demand for disposable insulin delivery devices. To achieve a significant market share, leading disposable insulin delivery device companies are focused on technological advances and the creation of innovative products.
High out-of-pocket expenditure in emerging economies and stringent government regulations are expected to hinder the growth of the market during the forecast period.
In addition, issues associated with the reuse of pen needles and infusion sets and poor reimbursement structure in developing countries are other factors expected to hamper the market growth.
Furthermore, stringent government rules and regulations governing the product approval process and the high cost of insulin analogs in diabetes care management could impede market growth in the near future.
| Category | By Distribution Channel |
|---|---|
| Top Segment | Hospital Pharmacies |
| Market Share in Percentage | 35.6% |
| Category | By Indication |
|---|---|
| Top Segment | Type II Diabetes |
| Market Share in Percentage | 78.4% |
Principal Consultant
In terms of regional platforms, North America holds a market share in the disposable insulin-delivery device market. The region captured a 33.4% share in 2022. Growth in the country is underpinned by the rising prevalence of diabetes, favorable government initiatives, a booming disposable insulin delivery device market, and the heavy presence of leading disposable insulin delivery device manufacturers.
North America is the biggest market to ensure compliance with business processes and legal issues. The region is expected to show significant growth in the market, attributed to the prevalence of diabetes and favorable reimbursement scenarios within the region. According to the Centers for Disease Control and Prevention (CDC), over 37.3 million people have diabetes in the United States.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| North America | 33.4% |
| Europe | 29.4% |
According to Future Market Insights, Europe is expected to provide immense growth opportunities for disposable insulin-delivery devices and reach a global share of 29.4% in 2022. Europe is expected to witness significant market growth, attributed to the rise in patient awareness of the disease in the region.
Europe is the second-leading contributor to the global disposable insulin delivery device market in terms of value due to the increasing prevalence of diabetes and the increase in healthcare expenditure for diabetes treatment in the various parts of Europe.
For instance, about 32.3 million adults were diagnosed with diabetes in the European Union in 2019, up from an estimated 16.8 million adults in 2000. An additional 24.2 million people in Europe were estimated to have diabetes but be undiagnosed in 2019. Thus, the large patient base suffering from diabetes and its growing prevalence is expected to boost the growth in this region.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| United States | 28.3% |
| Germany | 5.4% |
| Japan | 5.3% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
As per the analysis, the market in the Asia Pacific is projected to dominate the market during the forecast period. Disposable insulin delivery devices are widely used in Asian countries such as China and India. Factors such as increased diabetes awareness and an altering healthcare landscape are to blame for the increased sales of disposable insulin delivery devices in Asia Pacific countries.
Developing countries, like China and India, are expected to witness the highest growth during the study period due to a large population suffering from diabetes and its rising awareness among individuals. Furthermore, increased healthcare spending has resulted in increased adoption of technologically advanced products in countries such as China and India, which is projected to enhance market growth.
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| United Kingdom | 8.6% |
| China | 9.6% |
| India | 9% |
| Australia | 5.2% |
Many prominent market players in the overall market are working hand-in-hand to provide the best-in-class Disposable Insulin-Delivery Devices for enhancing the global insulin device arena. However, many international start-ups in the market are stepping forward to match the requirements of the Disposable Insulin-delivery Device domain.
Some start-ups operating in the disposable insulin-delivery device market are Tandem Diabetes, Insulet, Valeritas, Kaleido, Companion Medical, CeQur, Ypsomed, Aerami, EoFlow, and Sigrid Therapeutics.
In May 2022 - EOFlow Co., Ltd. announced the official launching of the iOS Version of ‘Narsha,' a smartphone application for wearable insulin pumps in Korea.
Some key participants present in the global disposable insulin-delivery device market include Animas Corporation, F. Hoffmann-La Roche AG, Insulet Corporation, Medtronic Plc., Valeritas, Inc., Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Inc. Abbott Laboratories, Becton Dickinson & Co., and EyeSense GmbH among others.
Due to several leading participants, the market is highly competitive-global players such as Animas Corporation, F. Hoffmann-La Roche AG, Insulet Corporation, and Medtronic Plc. Account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in North America.
Recent Developments
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 7.6% from 2023 to 2033 |
| Market Value in 2023 | US$ 15,780.6 million |
| Market Value in 2033 | US$ 32,814 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization & Pricing | Available Upon Request |
The disposable insulin-delivery device market is set to reach US$ 15,780.6 million in 2023.
The global disposable insulin-delivery device market is poised to achieve a revenue milestone of US$ 32,814 million by 2033.
A CAGR of 7.6% is predicted for the disposable insulin-delivery device market through 2033.
The disposable insulin-delivery device market in China is projected to exhibit 9.6% through 2033.
With a dominant market share of 78.4% in 2022, the type II diabetes segment leads the market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Delivery Pumps
5.3.2. Delivery Patches
5.3.3. Delivery Pens
5.3.4. Delivery Syringes
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Disease Indication, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Disease Indication, 2023 to 2033
6.3.1. Type I Diabetes
6.3.2. Type II Diabetes
6.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Disease Indication, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Sales
7.3.4. Diabetes Clinics
7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Disease Indication
9.2.4. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Disease Indication
9.3.4. By Distribution Channel
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Disease Indication
10.2.4. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Disease Indication
10.3.4. By Distribution Channel
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product Type
11.2.3. By Disease Indication
11.2.4. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Disease Indication
11.3.4. By Distribution Channel
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product Type
12.2.3. By Disease Indication
12.2.4. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Disease Indication
12.3.4. By Distribution Channel
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product Type
13.2.3. By Disease Indication
13.2.4. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Disease Indication
13.3.4. By Distribution Channel
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product Type
14.2.3. By Disease Indication
14.2.4. By Distribution Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Disease Indication
14.3.4. By Distribution Channel
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Disease Indication
15.2.4. By Distribution Channel
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Disease Indication
15.3.4. By Distribution Channel
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Disease Indication
16.1.2.3. By Distribution Channel
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Disease Indication
16.2.2.3. By Distribution Channel
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Disease Indication
16.3.2.3. By Distribution Channel
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Disease Indication
16.4.2.3. By Distribution Channel
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Disease Indication
16.5.2.3. By Distribution Channel
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Disease Indication
16.6.2.3. By Distribution Channel
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Disease Indication
16.7.2.3. By Distribution Channel
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Disease Indication
16.8.2.3. By Distribution Channel
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Disease Indication
16.9.2.3. By Distribution Channel
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Disease Indication
16.10.2.3. By Distribution Channel
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Disease Indication
16.11.2.3. By Distribution Channel
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Disease Indication
16.12.2.3. By Distribution Channel
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Disease Indication
16.13.2.3. By Distribution Channel
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Disease Indication
16.14.2.3. By Distribution Channel
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Disease Indication
16.15.2.3. By Distribution Channel
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Disease Indication
16.16.2.3. By Distribution Channel
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Disease Indication
16.17.2.3. By Distribution Channel
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Disease Indication
16.18.2.3. By Distribution Channel
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Disease Indication
16.19.2.3. By Distribution Channel
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Disease Indication
16.20.2.3. By Distribution Channel
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Disease Indication
16.21.2.3. By Distribution Channel
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product Type
16.22.2.2. By Disease Indication
16.22.2.3. By Distribution Channel
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product Type
16.23.2.2. By Disease Indication
16.23.2.3. By Distribution Channel
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Disease Indication
17.3.4. By Distribution Channel
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Animas Corporation
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. F. Hoffmann-La Roche AG
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Insulet Corporation
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Medtronic Plc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Valeritas, Inc.,
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Tandem Diabetes Care, Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Johnson & Johnson
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Beta Bionics Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Abbott Laboratories
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Becton Dickinson & Co.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. EyeSense GmbH
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Disposable Insulin-delivery Device Market
